Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03650348 |
Title | PRS-343 in Combination With Atezolizumab in HER2-Positive Solid Tumors |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Pieris Pharmaceuticals, Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
USC Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | United States | Details | |
Hoag Memorial Hospital Presbyterian | Newport Beach | California | 92663 | United States | Details | |
UCLA Health | Santa Monica | California | 90404 | United States | Details | |
Ochsner Cancer Institute | New Orleans | Louisiana | 70121 | United States | Details | |
Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
The Ohio State University Comprehensive Cancer Center | Columbus | Ohio | 43202 | United States | Details | |
M.D. Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
NEXT Oncology | San Antonio | Texas | 78240 | United States | Details |